0001104659-23-102819.txt : 20230921
0001104659-23-102819.hdr.sgml : 20230921
20230921161235
ACCESSION NUMBER: 0001104659-23-102819
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230921
DATE AS OF CHANGE: 20230921
EFFECTIVENESS DATE: 20230921
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: First Wave BioPharma, Inc.
CENTRAL INDEX KEY: 0001604191
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464993860
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-492736
FILM NUMBER: 231269242
BUSINESS ADDRESS:
STREET 1: 777 YAMATO ROAD
STREET 2: SUITE 502
CITY: BOCA RATON
STATE: FL
ZIP: 33431
BUSINESS PHONE: 561-589-7020
MAIL ADDRESS:
STREET 1: 777 YAMATO ROAD
STREET 2: SUITE 502
CITY: BOCA RATON
STATE: FL
ZIP: 33431
FORMER COMPANY:
FORMER CONFORMED NAME: AzurRx BioPharma, Inc.
DATE OF NAME CHANGE: 20141103
FORMER COMPANY:
FORMER CONFORMED NAME: BioPharma d'Azur, Inc.
DATE OF NAME CHANGE: 20140331
D
1
primary_doc.xml
X0708
D
LIVE
0001604191
First Wave BioPharma, Inc.
777 YAMATO ROAD
SUITE 502
BOCA RATON
FL
FLORIDA
33431
561-589-7020
DELAWARE
None
AzurRx BioPharma, Inc.
BioPharma d'Azur, Inc.
Corporation
true
James
Sapirstein
777 YAMATO ROAD
SUITE 502
BOCA RATON
FL
FLORIDA
33431
Executive Officer
Director
Sarah
Romano
777 YAMATO ROAD
SUITE 502
BOCA RATON
FL
FLORIDA
33431
Executive Officer
Terry
Coelho
777 YAMATO ROAD
SUITE 502
BOCA RATON
FL
FLORIDA
33431
Director
Edward
Borkowski
777 YAMATO ROAD
SUITE 502
BOCA RATON
FL
FLORIDA
33431
Director
Alastair
Riddell
777 YAMATO ROAD
SUITE 502
BOCA RATON
FL
FLORIDA
33431
Director
Charles
Casamento
777 YAMATO ROAD
SUITE 502
BOCA RATON
FL
FLORIDA
33431
Director
Biotechnology
Decline to Disclose
- 06b
false
2023-09-14
false
true
false
0
Roth Capital Partners, LLC
15407
None
None
888 SAN CLEMENTE
SUITE 400
NEWPORT BEACH
CA
CALIFORNIA
92660
All States
false
1470509
1470509
0
false
1
220000
0
0
true
Some of the proceeds may be used for general working capital purposes including the payment of salaries and other fees to those listed in Item 3.
false
First Wave BioPharma, Inc.
/s/ James Sapirstein
James Sapirstein
President and CEO
2023-09-21